This website uses cookies to improve your experience. You can accept or reject analytics cookies
Kansallinen Varautumissuunnitelma Influenssapandemiaa Varten
Pandemic Preparedness and ResponseNational Control Plan2012
FinlandEnglishPDF
National
AI-Generated Document Summary
Objectives
Finland’s national influenza-pandemic preparedness plan seeks to limit harm to population health and preserve the continuity of essential societal functions. It is designed principally for a severe pandemic, but is intended to be applied flexibly as evidence emerges about the severity, transmissibility and consequences of a new threat.
Prepare for an influenza A pandemic whose timing, virus subtype and severity cannot be predicted, using a severe first-wave planning scenario in which 35% of Finland’s population becomes infected over about eight weeks.
Reduce health, social and economic disruption through cross-sectoral cooperation, assigned responsibilities and continuity planning across public services and other societal sectors.
Maintain essential services, especially health and social care, despite high staff absence, increased workload and pressure on hospital capacity.
Detect influenza threats and outbreaks rapidly through epidemiological, clinical, virological and animal-health surveillance; use the resulting situation picture to guide proportionate decisions.
Prevent or delay a pandemic during World Health Organization alert phases through case detection, isolation, contact tracing, quarantine and targeted preventive medication; once sustained transmission occurs, focus on delaying the peak, reducing severe illness and deaths, and sustaining services.
Reduce transmission through hygiene, respiratory etiquette, keeping symptomatic people away from workplaces, social-distancing measures where justified, and possible restrictions affecting schools, childcare facilities and gatherings.
Secure timely access to pandemic vaccines, antiviral medicines, protective equipment and other critical supplies, while using ethically transparent approaches to allocate scarce resources.
Apply ethical principles of liberty, equity, health-benefit maximisation, efficiency, transparency, reasonableness and reciprocity when making decisions affecting individuals and communities.
Implementation
The plan uses a whole-of-government, phased implementation model grounded in Finland’s civilian crisis-management system and communicable-disease legislation. The Ministry of Social Affairs and Health leads national pandemic planning, guidance and supervision, while regional and local authorities retain major operational responsibilities for preparedness and service delivery.
Coordinate national action through the Government, the Prime Minister’s Office, the Ministry of Social Affairs and Health, the Finnish Institute for Health and Welfare, the Finnish Medicines Agency and other ministries and agencies. A Pandemic Coordination Group may support planning, direction and cross-sectoral measures during less severe disruptions, while a ministry command centre and situation-management system may be established during serious disturbances.
Assign each ministry responsibility for preparedness in its own sector, integrate relevant objectives into financial and operational plans and performance agreements, and require at least annual review of sectoral preparedness plans.
Direct, coordinate and supervise regional preparedness through Regional State Administrative Agencies, supported by hospital districts’ expertise; require regional plans to align municipal, primary-care, social-care and private-provider arrangements.
Place municipalities and joint municipal authorities at the centre of local service organisation, communicable-disease control and local response, while hospital districts provide specialist-care planning, regional expertise, diagnosis, outbreak investigation and support to health centres.
Integrate private health and social-care providers into preparedness planning and contracts, including responsibilities during exceptional circumstances, continuity requirements and allocation of exceptional costs.
Maintain surveillance through the national infectious diseases register, laboratory reporting, clinical and sentinel monitoring, virus characterisation, mortality monitoring, vaccination records and international information exchange. Laboratories report influenza findings, while the Finnish Institute for Health and Welfare leads national assessment, reference-laboratory functions and guidance.
Adapt case reporting and diagnostic intensity by pandemic phase, progressing from intensive investigation of suspected cases and clusters to surveillance of severe cases, hospital burden, deaths, viral characteristics, vaccine performance and antiviral use when case numbers rise.
Deliver vaccines through nationally coordinated procurement and distribution, with the Finnish Institute for Health and Welfare, wholesalers, hospital pharmacies, medicine centres, municipalities and joint municipal authorities responsible for linked logistics, cold-chain management and local administration.
Maintain emergency and mandatory stocks of medicines, antivirals, protective equipment and clinical supplies; monitor stock levels, medicine release, distribution, consumption and adverse effects through the relevant health and medicines authorities.
Prepare health services for surge demand by separating influenza patients where feasible, cohorting care, redeploying staff and premises, limiting non-urgent activity, expanding home-based care, planning reserve facilities and monitoring bed capacity and staff absence.
Coordinate public communication nationally and locally through the Ministry of Social Affairs and Health and the Finnish Institute for Health and Welfare, using accessible multilingual online information, media, telephone services and local channels. Monitor public information needs, misinformation and online-service resilience, and update guidance as circumstances change.
Review plans, undertake preparedness exercises and revise arrangements when threat assessments, operating conditions, legislation, evidence or international guidance change.
Monitoring & Evaluation
The plan establishes a phase-based monitoring and review system for influenza threats and pandemics, combining national, regional and local surveillance with international reporting, operational situation awareness, preparedness exercises and periodic plan revision. It does not set out a consolidated quantitative performance framework, but it assigns extensive surveillance, notification, supervisory and coordination responsibilities.
Monitor influenza through the National Institute for Health and Welfare (THL) infectious diseases register, laboratory reporting, virological characterisation, clinical surveillance, excess-mortality monitoring, population antibody surveys and international information exchange with the World Health Organization (WHO), European influenza surveillance networks and the European Centre for Disease Prevention and Control.
Require clinical microbiology laboratories to report influenza findings, including laboratory-confirmed cases and, during a pandemic, specified diagnostic volumes and positive results; use national reference-laboratory analysis to identify virus type, subtype, genetic change and antiviral resistance.
Expand surveillance during pandemic-threat phases through early telephone notification, case-based reporting, laboratory confirmation, exposure histories and collection of clinical and epidemiological data; simplify reporting as case numbers increase and comprehensive diagnosis becomes impracticable.
Track influenza-like illness, outpatient visits, emergency attendances, hospitalisations, intensive-care use, ventilator demand, deaths, staff absence, antiviral consumption, vaccine uptake and adverse effects to describe disease burden and pressure on health services.
Maintain phase-specific surveillance arrangements: preserve routine systems between pandemics, intensify detection and laboratory testing during pandemic-threat phases, and identify the onset, progression and end of regional epidemics during a pandemic.
Use vaccination records, batch traceability, adverse-event reporting and diagnosis-code monitoring to assess vaccine coverage, safety and unexpected clusters of serious illness following mass vaccination.
Require Regional State Administrative Agencies to supervise and coordinate regional preparedness planning and implementation, while municipalities and hospital districts provide local delivery, reporting and expert functions.
Require ministries to review their sectoral preparedness plans at least annually, submit material amendments for cross-government consideration and publish approved national-plan changes.
Test updated arrangements through preparedness exercises, including inter-sectoral cooperation, and use lessons learnt to revise plans where necessary.
Notify WHO within 24 hours of events that may constitute an international public-health emergency, including infections caused by a novel influenza subtype with pandemic potential.
Maintain real-time national and regional situation awareness through ministry command arrangements, regional reporting on service pressures and resource needs, and regular reporting to government leadership during serious disruption.
Evaluate pandemic impacts and control measures after the pandemic, assess the risk of further waves, use antibody studies where appropriate, and update national, regional and municipal plans.
Costing & Financing
The plan identifies substantial resource needs for preparedness, including vaccines, medicines, protective equipment, diagnostics, stockpiles, surge capacity, staffing, communication and continuity arrangements. However, it provides very limited quantified financing: most sections do not specify total budgets, programme costs, funding gaps, allocation formulas or economic assumptions.
Integrate preparedness objectives, where appropriate, into ministries’ financial and operational plans and performance agreements, and provide sufficient staffing for implementation guidance and cross-sector preparedness support.
Use an annual vaccine-delivery reservation fee within central-government budget proposals and spending-limit calculations; without a purchase-reservation agreement, vaccine availability and prices are uncertain.
Procure pandemic vaccines centrally and share pandemic-related additional costs between central government and municipalities or joint municipal authorities; identified cost areas include treatment, income losses, staff, medicines, vaccines, equipment, premises, training and social-security demand.
Fund occupational health services primarily through employers, with earned-income insurance compensation available up to an unspecified upper limit.
Finance health-insurance medicine reimbursements equally through insured persons’ medical-care contributions and the state financing share; medicines and treatment for diseases classified as generally hazardous communicable diseases are provided free of charge.
Maintain emergency and mandatory stocks of antivirals, antibiotics, vaccines, protective equipment, medical supplies and other essential materials, while recognising that stockholding based on normal consumption may not secure supplies for exceptional demand.
Require healthcare units to plan for their own purchases of medicines, supplies and protective equipment except where items are covered by national emergency stocks; targeted state appropriations may support regional expertise and preparedness capacity.
Recognise that private-service contracts should specify responsibility for exceptional costs arising from a pandemic or comparable event.
Use a 2012 contingency appropriation for unforeseen, necessary expenditure where no separate budget appropriation exists.
Recognise wider economic risks, including direct healthcare costs, productivity losses, disruption to tourism and trade, labour shortages and potentially longer-term reductions in gross domestic product.
Use scenario assumptions for resource planning rather than cost estimates, including a severe first wave in which 35% of the population becomes ill over approximately two months.